• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

CA 72-4 protein :: Cancer Antigen 72-4 Protein

Scan QR to view Datasheet
Catalog # MBS173393
Unit / Price
Scan QR to view Datasheet
  1000 Units  /  $150 +1 FREE 8GB USB
  5000 Units  /  $270 +1 FREE 8GB USB
  50000 Units  /  $1,355 +1 FREE 8GB USB
CA 72-4 protein
Product Name

Cancer Antigen 72-4 (CA 72-4), Protein

Popular Item
Full Product Name

Cancer Antigen 72-4 (CA 72-4), Human

Product Synonym Names
Cancer Antigen 72-4; Cancer Antigen 72-4 (CA 72-4)
Product Gene Name
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Human metastatic liver carcinoma
>= 90% (SDS-PAGE)
Appearance: Clear and colorless
100 KU/mL
If small volume, microfuge vial before drawing from container.
Preparation and Storage
At -20 degree C.
Shipping: Dry Ice
Avoid freeze thaw cycles.
Handle as a potentially hazardous substance.
Other Notes
Small volumes of CA 72-4 protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
CA 72-4 protein
MyBioSource is the leading producer and supplier of Cancer Antigen 72-4 (CA 72-4) for malignant diseases such as carcinomas of the pancreas, stomach, colon and ovaries.

Custom preparations, technical support, bulk quantities and aliquoting available.

Elevated CA 72-4 levels in serum and plasma have been reported in various malignant diseases including carcinomas of pancreas, stomach, gallbladder, colon, ovaries, cervix and endometrium. The highest diagnostic sensitivities, according to current studies, are found for carcinomas of the gastrointestinal tract and ovaries.

Although some benign diseases such as rheumatic diseases or ovary cysts may also result in elevated levels of CA 72-4, clinical studies demonstrated diagnostic specificity of more than 95% for gastrointestinal and ovarian malignancies. There is a good correlation between CA 72-4 levels and tumor stage and size.

CA 72-4 is the marker of choice for the therapeutic monitoring and follow-up care of gastrointestinal cancer patients. Suitable second markers are CA 19-9 or CEA. It has been used as an independent marker for the therapeutic monitoring and follow-up care of ovarian cancer patients, in particular in CA 125 negative patients.
Molecular Weight
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

Contact Us

Please fill out the form below and our representative will get back to you shortly.